ConductScience.org, home

Paper87269

Improved therapeutic index of bleomycin when administered by continuous infusion in mice.

Sikic BI and 3 others. Cancer Treat Rep, 1978. Cited by 130 papers, by iCite.

Cite this record

ConductScience Library. Improved therapeutic index of bleomycin when administered by continuous infusion in mice. Papers, record 87269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/87269

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improved therapeutic index of bleomycin when administered by continuous infusion in mice.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
6.8
iCite
Revised in PubMed
2022-03-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sikic BIB I
2Collins JMJ M
3Mimnaugh EGE G
4Gram TET E

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Lung NeoplasmsMajor topic
Animals
Dose-Response Relationship, Drug
Hydroxyproline
Lung
Male
Mice
Neoplasms, Experimental
Time Factors

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
25944801Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.Clin Cancer Res2015https://conductscience.org/library/papers/25944801PubMed
9085159Endoscopic local injection of a new drug delivery formulation, anticancer drug bound to carbon particles, for digestive cancers: pilot study.J Gastroenterol1997https://conductscience.org/library/papers/9085159PubMed
7190020Interaction of human serum albumin with anticancer agents in vitro.Br J Cancer1980https://conductscience.org/library/papers/7190020PubMed
7042294Rate-controlled drug dosage.Drugs1982https://conductscience.org/library/papers/7042294PubMed
6203661Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6203661PubMed
6199132Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6199132PubMed
6199131A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6199131PubMed
6190169Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6190169PubMed
6155927Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration.Br J Cancer1980https://conductscience.org/library/papers/6155927PubMed
6153937Lung damage from cytotoxic drugs.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6153937PubMed
3555940Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet1987https://conductscience.org/library/papers/3555940PubMed
3062572Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.Pharm Weekbl Sci1988https://conductscience.org/library/papers/3062572PubMed
2581717A pharmacokinetic evaluation of IM administration of bleomycin oil suspension.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/2581717PubMed
1723086Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.J Endocrinol Invest1991https://conductscience.org/library/papers/1723086PubMed
1711933Multivesicular liposomes containing bleomycin for subcutaneous administration.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1711933PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/87269

GET https://conductscience.org/api/papers/v1/87269/authors